Stay updated on TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial
Sign up to get notified when there's something new on the TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial page.

Latest updates to the TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision tag updated to v3.4.2; previous revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1; no substantive study information appears to be affected.SummaryDifference0.0%

- Check27 days agoChange DetectedUI changes include a glossary display option and revised QC/version labels (Last Update Submitted that Met QC Criteria and Revision: v3.4.0). Minor wording changes to policy text and versioning do not affect the study information.SummaryDifference0.2%

- Check42 days agoChange DetectedA new revision label v3.3.4 was added, replacing v3.3.3. No substantive changes to the study details or related content were observed.SummaryDifference0.0%

- Check63 days agoChange DetectedA new Locations section lists study sites in Arizona, Colorado, Florida, Georgia, New York, North Carolina, Ohio, Pennsylvania, and Virginia. The previous per-state location headings were removed and the revision updated to v3.3.3.SummaryDifference1.0%

- Check92 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. No substantive changes to study details, eligibility criteria, locations, or outcomes are visible.SummaryDifference0.0%

Stay in the know with updates to TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TVGV-1 Vaccine in HPV Cervical HSIL Clinical Trial page.